SPONSOR
Ohio State University Comprehensive Cancer Center
Total Trials
7
Recruiting
7
Phases
Phase 2, Phase 1
Conditions studied: Feasibility Pilot StudyComplianceTobacco-Related CarcinomaCutaneous MelanomaMerkel Cell CarcinomaSkin Squamous Cell CarcinomaHematopoietic and Lymphoid System NeoplasmMalignant Solid NeoplasmBlast Phase Chronic Myeloid Leukemia, BCR-ABL1 PositiveRecurrent Acute Lymphoblastic Leukemia
NCT06635005
Recruiting
A Low-Insulinemic Dietary Intervention to Reduce Breast Cancer Risk in High-Risk Women
Feasibility Pilot Study
NCT07346092
Recruiting
Studying the Health Perceptions and Social Behaviors of Graduate Students at the Ohio State University for the Development of Effective Oral Nicotine Pouch Addictive Risk Communication
Tobacco-Related Carcinoma
NCT06223659 Phase 2
Recruiting
EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers
Cutaneous Melanoma
NCT06314672
Recruiting
Outreach Project to Connect Underrepresented Populations to Clinical Trials at Ohio State University, CUSP2CT Project Trial
Hematopoietic and Lymphoid System Neoplasm
NCT07166419 Phase 1
Recruiting
Anti-CD19/20/22 Chimeric Antigen Receptor T Cells (TriCAR19.20.22 T Cells) for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, and Chronic Lymphocytic Leukemia
Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive
NCT07215065
Recruiting
Examining Heavy Metal Exposure and Respiratory Health in Young Adult Electronic Cigarette Users
Heavy Metal Exposure From Vaping
NCT05136846 Phase 1
Recruiting
Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer
Locally Advanced Lung Non-Small Cell Carcinoma